Found: 18
Select item for more details and to access through your institution.
SARS-CoV-2 Shedding from Asymptomatic Patients: Contribution of Potential Extrapulmonary Tissue Reservoirs.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2020, v. 103, n. 1, p. 18, doi. 10.4269/ajtmh.20-0279
- By:
- Publication type:
- Article
Validation of a Pseudovirus Neutralization Assay for Severe Acute Respiratory Syndrome Coronavirus 2: A High-Throughput Method for the Evaluation of Vaccine Immunogenicity.
- Published in:
- Microorganisms, 2024, v. 12, n. 6, p. 1201, doi. 10.3390/microorganisms12061201
- By:
- Publication type:
- Article
A Pseudovirus-Based Neutralization Assay for SARS-CoV-2 Variants: A Rapid, Cost-Effective, BSL-2–Based High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation.
- Published in:
- Microorganisms, 2024, v. 12, n. 3, p. 501, doi. 10.3390/microorganisms12030501
- By:
- Publication type:
- Article
A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection.
- Published in:
- Microorganisms, 2023, v. 11, n. 7, p. 1789, doi. 10.3390/microorganisms11071789
- By:
- Publication type:
- Article
Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation.
- Published in:
- Microorganisms, 2023, v. 11, n. 2, p. 368, doi. 10.3390/microorganisms11020368
- By:
- Publication type:
- Article
SARS-CoV-2 Spike Pseudoviruses: A Useful Tool to Study Virus Entry and Address Emerging Neutralization Escape Phenotypes.
- Published in:
- Microorganisms, 2021, v. 9, n. 8, p. 1744, doi. 10.3390/microorganisms9081744
- By:
- Publication type:
- Article
R430: A potent inhibitor of DNA and RNA viruses.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-33904-y
- By:
- Publication type:
- Article
Comparative Pathogenesis of Asian and African-Lineage Zika Virus in Indian Rhesus Macaque's and Development of a Non-Human Primate Model Suitable for the Evaluation of New Drugs and Vaccines.
- Published in:
- Viruses (1999-4915), 2018, v. 10, n. 5, p. 229, doi. 10.3390/v10050229
- By:
- Publication type:
- Article
Development of a Zika Virus Infection Model in Cynomolgus Macaques.
- Published in:
- Frontiers in Microbiology, 2016, v. 7, p. 1, doi. 10.3389/fmicb.2016.02028
- By:
- Publication type:
- Article
The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-0191-8
- By:
- Publication type:
- Article
Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical Trial.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 1, p. e4, doi. 10.1093/infdis/jiad508
- By:
- Publication type:
- Article
Strong CD4<sup>+</sup> T-Cell Responses to Ancestral and Variant Spike Proteins Are Established by NVX-CoV2373 Severe Acute Respiratory Syndrome Coronavirus 2 Primary Vaccination.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 6, p. 734, doi. 10.1093/infdis/jiad163
- By:
- Publication type:
- Article
Changes in the gut microbiome community of nonhuman primates following radiation injury.
- Published in:
- BMC Microbiology, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12866-021-02146-w
- By:
- Publication type:
- Article
2777. Live-Attenuated Vaccine Against RSV Generates Robust Cellular and Humoral Immune Responses.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S980, doi. 10.1093/ofid/ofz360.2454
- By:
- Publication type:
- Article
A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43578-w
- By:
- Publication type:
- Article
A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43578-w
- By:
- Publication type:
- Article
HBV Core Promoter Inhibition by Tubulin Polymerization Inhibitor (SRI-32007).
- Published in:
- Advances in Virology, 2020, p. 1, doi. 10.1155/2020/8844061
- By:
- Publication type:
- Article
Synergistic antiviral activity of Sofosbuvir and type-I interferons (α and β) against Zika virus.
- Published in:
- Journal of Medical Virology, 2018, v. 90, n. 1, p. 8, doi. 10.1002/jmv.24932
- By:
- Publication type:
- Article